"As part of our commitment to patients like you, we have a research department that participates in clinical studies. Through these studies, we are able to look at new ways to prevent, detect and treat diseases that may affect people in our community. Clinical research is at the center of all medical advances and plays a major role in improving the quality of medicine that is available to you and your loved ones. Thanks to those who have volunteered to take part in clinical research studies, the health of millions all over the world has been improved. Hattiesburg Clinic MediSync® Clinical Research is committed to providing new study opportunities to all the patients of Hattiesburg Clinic."

During the past decade, MediSync Clinical Research Hattiesburg Clinic conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MediSync Clinical Research Hattiesburg Clinic" #1 sponsor was "ModernaTX, Inc." with 3 trials, followed by "Cognoa, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Exact Sciences Corporation" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MediSync Clinical Research Hattiesburg Clinic" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MediSync Clinical Research Hattiesburg Clinic" are "SARS-CoV-2" (2 trials), "Autism Spectrum Disorder" (1 trials), "Cytomegalovirus Infection" (1 trials), "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "MediSync Clinical Research Hattiesburg Clinic" in a lesser frequency.

Most popular intervention types in "MediSync Clinical Research Hattiesburg Clinic" are "Biological" (5 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "mRNA-1273" (2 trials), "Ad26.COV2.S" (1 trials), "Blood Sample Collection" (1 trials) and "Cognoa ASD diagnostic device" (1 trials). Other intervention names were less common.

The vast majority of trials in "MediSync Clinical Research Hattiesburg Clinic" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MediSync Clinical Research Hattiesburg Clinic". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in MediSync Clinical Research Hattiesburg Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MediSync Clinical Research Hattiesburg Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".